To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic steatohepatitis (NASH).
- Status
- Accepting Candidates
- Ages
- 21 Years - 75 Years
- Sexes
- All
A liver biopsy is a test that takes a sample of tissue from the liver for examination.
Biopsy - liver; Percutaneous liver biopsy; Needle biopsy of liver
Most of the time, the test is done in the hospital or specialized procedure unit. Before the test is done, you may be given a medicine to prevent pain or to calm you (sedative).
The biopsy may be done through the abdominal wall:
The procedure can also be done by inserting a needle into your liver by moving it through the jugular vein.
If you receive sedation for this test, you will need someone to drive you home.
Tell your provider about:
You must sign a consent form. Blood tests are sometimes done to test your blood's ability to clot. You will be told not to eat or drink anything for the 8 hours before the test.
For infants and children:
The preparation needed for a child depends on the child's age and maturity. Your child's provider will tell you what you can do to prepare your child for this test.
You will feel a stinging pain when the anesthetic is injected. The biopsy needle may feel like deep pressure and dull pain. Some people feel this pain in the shoulder.
The biopsy helps diagnose many liver diseases. The procedure also helps assess the stage (early, advanced) of liver disease. This is especially important in hepatitis B and C infection.
The biopsy also helps detect:
The liver tissue is normal.
The biopsy may reveal a number of liver diseases, including cirrhosis, hepatitis, or infections such as tuberculosis. It may also indicate cancer.
This test also may be performed for:
Risks may include:
Holmes JA, Chung RT. Hepatitis C. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 80.
Martin P. Approach to the patient with liver disease. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 137.
Paradis V, Zucman-Rossi J. Cellular and molecular techniques. In: Burt AD, ed. MacSween's Pathology of the Liver. 8th ed. Philadelphia, PA: Elsevier; 2024:chap 2.
UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic steatohepatitis (NASH).
September 1, 2020
Allen Korson went from a kidney stone ailment to needing a multiorgan transplant, both lungs and a liver, one of the rarest procedures performed in the United…
Department of Surgery, +2 more
Robert “Bobby” Murray, 34, was born in Hollywood, Florida on Jan. 23, 1985 – during a decade in which long-term survival into adulthood for a person with…